Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVBP | Common Stock | Conversion of derivative security | +822K | 822K | Jan 30, 2024 | See footnotes | F1, F2, F4 | |||
transaction | AVBP | Common Stock | Conversion of derivative security | +822K | 822K | Jan 30, 2024 | See footnotes | F1, F3, F4 | |||
transaction | AVBP | Common Stock | Conversion of derivative security | +470K | +57.14% | 1.29M | Jan 30, 2024 | See footnotes | F1, F2, F4 | ||
transaction | AVBP | Common Stock | Conversion of derivative security | +470K | +57.14% | 1.29M | Jan 30, 2024 | See footnotes | F1, F3, F4 | ||
transaction | AVBP | Common Stock | Purchase | $4M | +222K | +17.21% | $18.00* | 1.51M | Jan 30, 2024 | See footnotes | F2, F4, F5 |
transaction | AVBP | Common Stock | Purchase | $4M | +222K | +17.21% | $18.00* | 1.51M | Jan 30, 2024 | See footnotes | F3, F4, F5 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVBP | Series A Preferred Stock | Conversion of derivative security | -822K | -100% | 0 | Jan 30, 2024 | Common Stock | 822K | See footnotes | F1, F2, F4, F6 | |||
transaction | AVBP | Series A Preferred Stock | Conversion of derivative security | -822K | -100% | 0 | Jan 30, 2024 | Common Stock | 822K | See footnotes | F1, F3, F4, F6 | |||
transaction | AVBP | Series B Preferred Stock | Conversion of derivative security | -470K | -100% | 0 | Jan 30, 2024 | Common Stock | 470K | See footnotes | F1, F2, F4, F6 | |||
transaction | AVBP | Series B Preferred Stock | Conversion of derivative security | -470K | -100% | 0 | Jan 30, 2024 | Common Stock | 470K | See footnotes | F1, F3, F4, F6 |
Id | Content |
---|---|
F1 | The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 15.21-for-1 basis. |
F2 | These securities are held of record by OrbiMed Asia Partners IV, L.P. ("OAP IV"). OrbiMed Asia GP IV, L.P. ("Asia GP IV") is the general partner of OAP IV and OrbiMed Advisors IV Limited ("Advisors IV") is the general partner of Asia GP IV. OrbiMed Advisors LLC ("OrbiMed Advisors") is the advisory company of OAP IV. By virtue of such relationships, Asia GP IV, Advisors IV, and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by OAP IV and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OAP IV. |
F3 | These securities are held of record by OrbiMed Private Investments VIII, L.P. ("OPI VIII"). OrbiMed Capital GP VIII LLC ("GP VIII") is the general partner of OPI VIII and OrbiMed Advisors is the managing member of GP VIII. The Reporting Person is a member of OrbiMed Advisors. By virtue of such relationships, GP VIII and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by OPI VIII and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPI VIII. |
F4 | Each of OrbiMed Advisors, GP VIII, Advisors IV, Asia GP IV, and the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for purpose of Section 16 of the Exchange Act, or for any other purpose. |
F5 | Reflects shares purchased in the Issuer's initial public offering. |
F6 | The shares of preferred stock were convertible into the Issuer's common stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering. |